Nearly Two in Three Eosinophilic Esophagitis Patients on Tezspire Reached Tissue Remission After One Year of Treatment
In a Phase 3 trial, Tezspire put most eosinophilic esophagitis patients in tissue remission at one year. What does it mean for swallowing and approval?
Medical Daily ·